US Stock MarketDetailed Quotes

BMEZ Blackrock Health Sciences Trust II

Watchlist
  • 15.175
  • -0.145-0.95%
Trading Mar 11 11:44 ET
1.58BMarket Cap72.26P/E (TTM)

Blackrock Health Sciences Trust II Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q2)Jun 30, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q2)Jun 30, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q2)Jun 30, 2022
(FY)Dec 31, 2021
Assets
Cash cash equivalents and federal funds sold
-71.97%128.15K
-71.97%128.15K
-56.49%16.14K
1,165.87%457.17K
1,165.87%457.17K
-69.79%37.1K
-76.83%36.12K
--36.12K
-90.03%122.81K
-87.67%155.88K
-Cash and cash equivalents
10,871.49%128.15K
10,871.49%128.15K
-87.12%141
915.65%1.17K
915.65%1.17K
-98.74%1.1K
-99.90%115
--115
12,126.76%86.81K
11,828.66%119.88K
-Restricted cash and investments
----
----
-55.56%16K
1,166.67%456K
1,166.67%456K
0.00%36K
0.00%36K
--36K
-97.08%36K
-97.15%36K
Receivables
-29.47%1.05M
-29.47%1.05M
-86.94%2.33M
46.84%1.48M
46.84%1.48M
1,349.83%17.87M
-34.01%1.01M
--1.01M
-75.69%1.23M
18.44%1.53M
Prepaid assets
-46.46%8.65K
-46.46%8.65K
--20.5K
--16.16K
--16.16K
----
----
----
--0
139.26%48.37K
-Available for sale securities
----
----
--105.23M
----
----
----
----
----
----
----
Derivative assets
----
----
----
-71.21%1.43M
-71.21%1.43M
--963.12K
--4.96M
--4.96M
----
----
Deferred costs
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
-13.65%1.69B
-13.65%1.69B
-10.77%1.92B
-6.32%1.95B
-6.32%1.95B
0.12%2.15B
-30.89%2.09B
--2.09B
-38.18%2.15B
-14.84%3.02B
Liabilities
Payables
1.52%2.65M
1.52%2.65M
-84.55%5.74M
-70.32%2.61M
-70.32%2.61M
527.39%37.16M
8.51%8.79M
--8.79M
-29.42%5.92M
-62.61%8.1M
-Accounts payable
--0
--0
-92.56%2.27M
----
----
882.03%30.54M
-37.23%2.9M
--2.9M
-5.26%3.11M
-74.39%4.62M
-Other payable
1.52%2.65M
1.52%2.65M
-47.55%3.47M
-55.69%2.61M
-55.69%2.61M
135.24%6.62M
69.30%5.89M
--5.89M
-44.94%2.81M
-3.77%3.48M
Long term debt and capital lease obligation
----
----
--18.9K
206.23%291.88K
206.23%291.88K
----
--95.31K
--95.31K
-95.52%69.8K
----
Derivative product liabilities
-66.78%10.44M
-66.78%10.44M
-11.44%17.85M
69.94%31.43M
69.94%31.43M
2.23%20.15M
-20.09%18.5M
--18.5M
-46.54%19.71M
-53.47%23.15M
Other liabilities
-16.85%10.23M
-16.85%10.23M
-25.06%29.18M
572.17%12.3M
572.17%12.3M
467.74%38.94M
-62.96%1.83M
--1.83M
9.82%6.86M
-48.42%4.94M
Total liabilities
-49.81%23.44M
-49.81%23.44M
-45.11%52.89M
58.83%46.7M
58.83%46.7M
193.66%96.35M
-19.19%29.4M
--29.4M
-38.98%32.81M
-55.43%36.38M
Shareholders'equity
Share capital
-13.62%1.69B
-13.62%1.69B
-9.35%1.95B
-10.41%1.95B
-10.41%1.95B
-4.08%2.15B
-3.36%2.18B
--2.18B
-0.42%2.24B
0.00%2.25B
-common stock
-13.62%1.69B
-13.62%1.69B
-9.35%1.95B
-10.41%1.95B
-10.41%1.95B
-4.08%2.15B
-3.36%2.18B
--2.18B
-0.42%2.24B
0.00%2.25B
Retained earnings
51.11%-21.36M
51.11%-21.36M
13.38%-81.07M
63.99%-43.69M
63.99%-43.69M
24.71%-93.6M
-116.65%-121.32M
---121.32M
-110.58%-124.32M
-39.76%728.49M
Total stockholders'equity
-12.77%1.66B
-12.77%1.66B
-9.16%1.87B
-7.25%1.91B
-7.25%1.91B
-2.88%2.06B
-31.04%2.06B
--2.06B
-38.17%2.12B
-13.88%2.98B
Total equity
-12.77%1.66B
-12.77%1.66B
-9.16%1.87B
-7.25%1.91B
-7.25%1.91B
-2.88%2.06B
-31.04%2.06B
--2.06B
-38.17%2.12B
-13.88%2.98B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
Unqualified Opinion
--
--
Unqualified Opinion
--
--
Unqualified Opinion
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q2)Jun 30, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q2)Jun 30, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q2)Jun 30, 2022(FY)Dec 31, 2021
Assets
Cash cash equivalents and federal funds sold -71.97%128.15K-71.97%128.15K-56.49%16.14K1,165.87%457.17K1,165.87%457.17K-69.79%37.1K-76.83%36.12K--36.12K-90.03%122.81K-87.67%155.88K
-Cash and cash equivalents 10,871.49%128.15K10,871.49%128.15K-87.12%141915.65%1.17K915.65%1.17K-98.74%1.1K-99.90%115--11512,126.76%86.81K11,828.66%119.88K
-Restricted cash and investments ---------55.56%16K1,166.67%456K1,166.67%456K0.00%36K0.00%36K--36K-97.08%36K-97.15%36K
Receivables -29.47%1.05M-29.47%1.05M-86.94%2.33M46.84%1.48M46.84%1.48M1,349.83%17.87M-34.01%1.01M--1.01M-75.69%1.23M18.44%1.53M
Prepaid assets -46.46%8.65K-46.46%8.65K--20.5K--16.16K--16.16K--------------0139.26%48.37K
-Available for sale securities ----------105.23M----------------------------
Derivative assets -------------71.21%1.43M-71.21%1.43M--963.12K--4.96M--4.96M--------
Deferred costs --0--0--0--0--0--0--0--0--0--0
Total assets -13.65%1.69B-13.65%1.69B-10.77%1.92B-6.32%1.95B-6.32%1.95B0.12%2.15B-30.89%2.09B--2.09B-38.18%2.15B-14.84%3.02B
Liabilities
Payables 1.52%2.65M1.52%2.65M-84.55%5.74M-70.32%2.61M-70.32%2.61M527.39%37.16M8.51%8.79M--8.79M-29.42%5.92M-62.61%8.1M
-Accounts payable --0--0-92.56%2.27M--------882.03%30.54M-37.23%2.9M--2.9M-5.26%3.11M-74.39%4.62M
-Other payable 1.52%2.65M1.52%2.65M-47.55%3.47M-55.69%2.61M-55.69%2.61M135.24%6.62M69.30%5.89M--5.89M-44.94%2.81M-3.77%3.48M
Long term debt and capital lease obligation ----------18.9K206.23%291.88K206.23%291.88K------95.31K--95.31K-95.52%69.8K----
Derivative product liabilities -66.78%10.44M-66.78%10.44M-11.44%17.85M69.94%31.43M69.94%31.43M2.23%20.15M-20.09%18.5M--18.5M-46.54%19.71M-53.47%23.15M
Other liabilities -16.85%10.23M-16.85%10.23M-25.06%29.18M572.17%12.3M572.17%12.3M467.74%38.94M-62.96%1.83M--1.83M9.82%6.86M-48.42%4.94M
Total liabilities -49.81%23.44M-49.81%23.44M-45.11%52.89M58.83%46.7M58.83%46.7M193.66%96.35M-19.19%29.4M--29.4M-38.98%32.81M-55.43%36.38M
Shareholders'equity
Share capital -13.62%1.69B-13.62%1.69B-9.35%1.95B-10.41%1.95B-10.41%1.95B-4.08%2.15B-3.36%2.18B--2.18B-0.42%2.24B0.00%2.25B
-common stock -13.62%1.69B-13.62%1.69B-9.35%1.95B-10.41%1.95B-10.41%1.95B-4.08%2.15B-3.36%2.18B--2.18B-0.42%2.24B0.00%2.25B
Retained earnings 51.11%-21.36M51.11%-21.36M13.38%-81.07M63.99%-43.69M63.99%-43.69M24.71%-93.6M-116.65%-121.32M---121.32M-110.58%-124.32M-39.76%728.49M
Total stockholders'equity -12.77%1.66B-12.77%1.66B-9.16%1.87B-7.25%1.91B-7.25%1.91B-2.88%2.06B-31.04%2.06B--2.06B-38.17%2.12B-13.88%2.98B
Total equity -12.77%1.66B-12.77%1.66B-9.16%1.87B-7.25%1.91B-7.25%1.91B-2.88%2.06B-31.04%2.06B--2.06B-38.17%2.12B-13.88%2.98B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion----Unqualified Opinion----Unqualified Opinion----Unqualified Opinion
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Alibaba
BABA
+4.63%
Broadcom
AVGO
+4.51%
Tesla
TSLA
+4.29%
Netflix
NFLX
+3.89%
NVIDIA
NVDA
+2.92%

Unlock the Full List